Barclays PLC (BCS) vs Marex Group Limited (MRX)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| BCS | MRX | |
|---|---|---|
| Sector | Financial Services | Financial Services |
| Industry | Banks - Diversified | Capital Markets |
| Size band | LARGE | MID |
| Listing | NYSE | Nasdaq GS |
| Country | United Kingdom | United Kingdom |
| Theme | money-center-banks | brokerage-and-exchanges |
| Price and returns | ||
| Last close | $22.27 | $70.73 |
| Return · 1 week | +0.45% | +1.55% |
| Return · 1 month | −9.51% | −0.79% |
| Return · 3 months | −16.53% | +10.24% |
| Return · year to date | −13.49% | +87.76% |
| Return · 1 year | +5.96% | +132.08% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −22.38% | −10.59% |
| 52-week high | $28.69 | $79.11 |
| 52-week low | $19.49 | $29.91 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $74.22B | $5.17B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $85.25M | $49.69M |
| Employees | 93,000 | 3,347 |
| Valuation | ||
| Price to earnings · trailing | 8.11× | 14.53× |
| Price to earnings · forward | 6.83× | 10.95× |
| Price to sales | 2.55× | — |
| Price to book | 0.85× | 3.80× |
| Enterprise value to revenue | 2.38× | 1.84× |
| PEG ratio | 0.83 | — |
| Earnings per share · trailing | 2.68 | 4.95 |
| Profitability | ||
| Gross margin | — | 46.54% |
| Operating margin | 32.23% | 17.16% |
| Profit margin | 24.70% | 10.77% |
| Return on equity | 10.45% | 26.24% |
| Return on assets | 0.48% | 1.07% |
| Growth | ||
| Revenue growth | +4.90% | +32.10% |
| Earnings growth | +17.80% | +105.30% |
| Balance sheet and payout | ||
| Debt / equity (%) | — | 825.02 |
| Current ratio | — | 1.09 |
| Dividend yield | 2.84% | 0.90% |
| Payout ratio | 22.96% | 12.32% |
| Trend and volatility | ||
| RSI · 14 | 34.81 | 48.75 |
| ADX · 14 | 39.51 | 15.81 |
| 50-day average | $24.90 | $72.12 |
| 200-day average | $24.92 | $56.57 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 2.34% | 4.32% |
The full BCS analysis
Everything this table leaves out for Barclays PLC: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BCS argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BCS analysisThe full MRX analysis
Everything this table leaves out for Marex Group Limited: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the MRX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full MRX analysis